中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 10
Oct.  2014
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2014  >  30(10): 1067-1070

Clinical efficacy of puerarin combined with compound ammonium glycyrrhetate S in treatment of alcoholic hepatitis

DOI: 10.3969/j.issn.1001-5256.2014.10.023

  • The 97th Hospital of PLA

Research funding:

 

  • Received Date: 2014-07-28
  • Published Date: 2014-10-20
    Abstract

  • Objective To investigate the clinical efficacy of puerarin combined with compound ammonium glycyrrhetate S in the treatment of alcoholic hepatitis. Methods A total of 92 patients with alcoholic hepatitis who were admitted to our hospital from February 2011 to February 2014 were recruited in this study and randomly divided into two groups. The control group ( n = 46) was treated with conventional therapy combined with compound ammonium glycyrrhetate S. The test group ( n = 46) was treated with puerarin in addition to the regimen used in the control group. After 20 days of treatment, the levels of total bilirubin ( TBil) , alanine aminotransferase ( ALT) , aspartate aminotransferase ( AST) , glutamyl transpeptidase ( GGT) , albumin ( Alb) , Glasgow alcoholic hepatitis score ( GAHS) , and abdominal ultrasound were measured and compared with the results before the treatment in both groups. The clinical efficacy and adverse reactions in the two groups were also compared. Results After the treatment, the GAHSs and levels of TBil, ALT, AST, and GGT in the two groups were all significantly lower than those before the treatment ( all P < 0. 05) . In the test group after the treatment, the levels of TBil ( 20. 96 ± 6. 85μmol/L) , ALT ( 33. 72 ±14. 18 U/L) , and AST ( 38. 69 ±6. 38 U/L) were all significantly lower than those in the control group ( all P<0. 05) . The marked response rate, overall response rate, and rate of improvement in abdominal ultrasound in the test group were 63. 04%, 93. 48%, and 44. 44%, respectively, all significantly higher than those in the control group ( all P < 0. 05) . There was no significant difference in adverse reactions between the two groups ( P >0. 05) . Conclusion For patients with alcoholic hepatitis, the combined therapy with puerarin and compound ammonium glycyrrhetate S can improve the treatment outcome and protect the liver function, and it has high safety and holds promise for clinical application.

     

    • FullText(HTML)
  • loading
    • References(18)
  • [1]LI YM.Epidemiological characteristics of alcoholic liver disease[J].J Pract Hepatol, 2012, 15 (3) :180-182. (in Chinese) 厉有名.酒精性肝病的流行病学特点[J].实用肝脏病杂志, 2012, 15 (3) :180-182.
    [2]SOHAIL U, SATAPATHY SK.Diagnosis and management of alcoholic hepatitis[J].Clin Liver Dis, 2012, 16 (4) :717-736.
    [3] Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association, Chinese Medical Association.Guidelines for prevention and treatment of alcoholic liver disease (revised version 2010) [J].J Clin Hepatol, 2010, 26 (3) :229-232. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南 (2010修订版) [J].临床肝胆病杂志, 2010, 26 (3) :229-232.
    [4]WU KM, HE CW.Effect of magnesium isoglycyrrhizinate in treatment of alcoholic hepatitis[J].China Med, 2012, 7 (10) :1263-1264. (in Chinese) 吴况明, 何蔡为.异甘草酸镁对酒精性肝炎的疗效观察[J].中国医药, 2012, 7 (10) :1263-1264.
    [5]CHANG BX, WANG H, ZHOU ZS, et al.Pathogenesis and novel therapeutic targets of alcoholic liver disease[J].J Clin Hepatol, 2014, 30 (2) :113-117. (in Chinese) 常彬霞, 王华, 邹正升.酒精性肝病的发病机理和新的治疗靶点[J].临床肝胆病杂志, 2014, 30 (2) :113-117.
    [6]WANG HY, LI X, XU YQ.Progress in the pathogenesis of alcoholic liver disease[J].J Pract Hepatol, 2014, 17 (1) :5-8. (in Chinese) 王洪岩, 李鑫, 徐有青.酒精性肝病发病机制研究进展[J].实用肝脏病杂志, 2014, 17 (1) :5-8.
    [7]ANTAR R, WONG P, GHALI P, et al.A meta-analysis of nutritional supplementation for management of hospitalized alcoholic hepatitis[J].Can J Gastroenterol, 2012, 26 (7) :463-467.
    [8]HUANG H, CHEN H, XU YH, et al.Quality control of ammonium glycyrrhinate[J].Chin Tradit Patent Med, 2013, 35 (10) :2199-2204. (in Chinese) 黄浩, 程荷, 徐云辉, 等.我国甘草酸铵盐原料药质量控制方法的研究探讨[J].中成药, 2013, 35 (10) :2199-2204.
    [9]GAO J.Efficacy of compound monoammonium glycyrrhizinate injection in treatment of ulcerative colitis:a report of 100 cases[J].China Pharm, 2008, 17 (17) :50. (in Chinese) 高洁.复方甘草酸单铵注射液治疗溃疡性结肠炎100例[J].中国药业, 2008, 17 (17) :50.
    [10]CHEN BC.Effect of compound monoammonium glycyrrhizinate S combined with Xueshuantong on liver fibrosis indices in patients with chronic hepatitis B[J].Intern Med China, 2013, 8 (4) :360-361. (in Chinese) 陈北昌.复方甘草酸单铵S联合血栓通对慢性乙肝患者肝纤维化指标的影响[J].内科, 2013, 8 (4) :360-361.
    [11]HUANG XQ.Analysis on the efficacy of compound ammonium glycyrrhetate S in the treatment of antituberculosis drugs induced liver injury[J].Heilongjiang Med J, 2012, 36 (6) :436-438. (in Chinese) 黄修秋.复方甘草酸单铵S治疗抗结核药肝损害疗效及不良反应分析[J].黑龙江医学, 2012, 36 (6) :436-438.
    [12]JI YK, ZHANG GF.Effect of compound ammonium glycyrrhetate S in preventing and curing hepatic injury caused by chemotherapy[J].Chin J Gen Pract, 2010, 8 (6) :696-697. (in Chinese) 姬永科, 张桂芳.莫邦防治化疗药物性肝损伤临床观察[J].中华全科医学, 2010, 8 (6) :696-697.
    [13]WEI W, JIANG P.Progress of research on Puerarin pharmacological action[J].Heilongjiang Med J, 2014, 26 (1) :985-986. (in Chinese) 伟唯, 江培.葛根素药理作用研究进展[J].黑龙江医药, 2014, 26 (1) :985-986.
    [14]FANG DM, ZHU Y, MING YZ, et al.Hepatoprotective effects of puerarin on brain death rats[J].Chin J Gen Surg, 2011, 20 (5) :503-506. (in Chinese) 方达明, 朱毅, 明英姿, 等.葛根素对脑死亡大鼠肝脏的保护作用[J].中国普通外科杂志, 2011, 20 (5) :503-506.
    [15]QU ZW, WEN CY, WANG AP, et al.Protective effect of puerarin on rats with alcoholic hepatitis[J].World Chin J Dig, 2009, 17 (7) :657-661. (in Chinese) 曲智威, 温春阳, 王爱平, 等.葛根素对大鼠酒精性肝炎的影响及其机制[J].世界华人消化杂志, 2009, 17 (7) :657-661.
    [16]WU GL, CHEN J, YU GY, et al.Effect of puerarin on levels of TGF-β1 andα-SMA in rats with alcoholic injury liver[J].China J Chin Mater Med, 2008, 33 (19) :2245-2249. (in Chinese) 吴国琳, 陈玖, 余国友, 等.葛根素对酒精性肝损伤大鼠肝组织TGF-β1和α-SMA表达的影响[J].中国中药杂志, 2008, 33 (19) :2245-2249.
    [17]LU WW, CHEN J, WU GL, et al.Influences on serum transaminase and hepatic fibrosis of alcohilic liver damage rats treated with puerarin[J].Zhejiang J Tradit Chin Med, 2008, 43 (1) :7-9. (in Chinese) 卢雯雯, 陈玖, 吴国琳, 等.葛根素对酒精性肝损伤大鼠血清转氨酶及肝纤维化指标的影响[J].浙江中医杂志, 2008, 43 (1) :7-9.
    [18]GU CH, LIU X.Protective efficacy of puerarin on acute hepatic injury of mice induced by alcohol[J].Jiangsu J Prevent Med, 2006, 17 (3) :69-70. (in Chinese) 顾呈华, 刘协.葛根素对酒精诱发小鼠急性肝损伤的保护作用[J].江苏预防医学, 2006, 17 (3) :69-70.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (2605) PDF downloads(603) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return